Research Participation Among American Indian and Alaskan Native Individuals Living With Parkinson’s Disease
Fuente:
Wiley Open Access
Salvato in:
| Autori principali: | Jacob D. Jones, Yenny Valenzuela, Melissa Pacheco, Lonnie Nelson |
|---|---|
| Natura: | Artículo Open Access |
| Pubblicazione: |
Wiley
2025
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Documenti analoghi
Association of Specific Leg Muscle Strength and Motor Features in Parkinson’s Disease
di: Chatkaew Pongmala, et al.
Pubblicazione: (2024)
di: Chatkaew Pongmala, et al.
Pubblicazione: (2024)
A Cognitive‐Behavioral Model of Apathy in Parkinson’s Disease
di: Olivia Plant, et al.
Pubblicazione: (2024)
di: Olivia Plant, et al.
Pubblicazione: (2024)
Trait Impulsivity as a Feature of Parkinson’s Disease Treatment and Progression
di: Holly Spencer, et al.
Pubblicazione: (2024)
di: Holly Spencer, et al.
Pubblicazione: (2024)
Feasibility and Acceptability of Intervention and Trial Procedures of the UCL Live Well With Parkinson’s Self‐Management Toolkit
di: Tasmin Rookes, et al.
Pubblicazione: (2025)
di: Tasmin Rookes, et al.
Pubblicazione: (2025)
Daily Fluid Intake in People With Newly Diagnosed Parkinson’s Disease Is Reduced Compared With Controls
di: Isobel J. Sleeman, et al.
Pubblicazione: (2025)
di: Isobel J. Sleeman, et al.
Pubblicazione: (2025)
Determining Medication Adherence in Patients Treated for Parkinson’s Disease and Related Factors
di: Mahboobeh Besharatpour, et al.
Pubblicazione: (2025)
di: Mahboobeh Besharatpour, et al.
Pubblicazione: (2025)
Cystatin C Secretion in Blood Derivatives and Cellular Models of Idiopathic Parkinson’s Disease
di: Kathleen Mommaerts, et al.
Pubblicazione: (2025)
di: Kathleen Mommaerts, et al.
Pubblicazione: (2025)
Mucuna pruriens Treatment for Parkinson Disease: A Systematic Review of Clinical Trials
di: Fatima Hammoud, et al.
Pubblicazione: (2025)
di: Fatima Hammoud, et al.
Pubblicazione: (2025)
Serum GDF‐15 Levels Correlate With Motor and Nonmotor Symptom Domains and Overall Disease Severity in Patients With Parkinson’s Disease
di: Noriyuki Miyaue, et al.
Pubblicazione: (2026)
di: Noriyuki Miyaue, et al.
Pubblicazione: (2026)
Identification of Gene Signatures and Molecular Mechanisms for Diagnosing Parkinson’s Disease and Nonalcoholic Fatty Liver Disease Using Machine Learning
di: Xuan Chen, et al.
Pubblicazione: (2026)
di: Xuan Chen, et al.
Pubblicazione: (2026)
Views and Experiences of Online Exercise Groups for People With Parkinson’s Disease: A Qualitative Study
di: James Alexander, et al.
Pubblicazione: (2026)
di: James Alexander, et al.
Pubblicazione: (2026)
Improvement by Medication Less than Expected in Parkinson’s Disease: Blinded Evaluation of Levodopa Response
di: Mette Niemann Johansen, et al.
Pubblicazione: (2024)
di: Mette Niemann Johansen, et al.
Pubblicazione: (2024)
Mental Fatigue in Parkinson’s Disease: Systematic Review and Evaluation of Self‐Reported Fatigue Scales
di: Junle Chen, et al.
Pubblicazione: (2024)
di: Junle Chen, et al.
Pubblicazione: (2024)
Possible Implications of Managing Alexithymia on Quality of Life in Parkinson’s Disease: A Systematic Review
di: Laura Culicetto, et al.
Pubblicazione: (2024)
di: Laura Culicetto, et al.
Pubblicazione: (2024)
Factors Influencing Pain Management Practices in People With Parkinson’s Disease: A Qualitative Descriptive Study
di: Anthony Mezzini, et al.
Pubblicazione: (2025)
di: Anthony Mezzini, et al.
Pubblicazione: (2025)
Towards a Biologically Defined Diagnosis: Incorporating Pathophysiological Measures Into Parkinson’s Disease Clinical Criteria
di: Angus McNamara, et al.
Pubblicazione: (2026)
di: Angus McNamara, et al.
Pubblicazione: (2026)
A Systematic Review and Meta-Analysis of the Efficacy and Safety of Rasagiline or Pramipexole in the Treatment of Early Parkinson’s Disease
di: Pauli Seppänen, et al.
Pubblicazione: (2024)
di: Pauli Seppänen, et al.
Pubblicazione: (2024)
Oxidative Stress: A New Pathophysiological Pathway in Parkinson’s Disease and a Potential Target of the Brain‐Sport Crosstalk
di: Stefano Caproni, et al.
Pubblicazione: (2025)
di: Stefano Caproni, et al.
Pubblicazione: (2025)
Clove Essential Oil Enhances Antioxidant Defenses and Reduces DNA Damage in a Cellular Model of Parkinson’s Disease
di: Dhouha Hamdi, et al.
Pubblicazione: (2025)
di: Dhouha Hamdi, et al.
Pubblicazione: (2025)
Changes in Visual Evoked Potential and Optical Coherence Tomography in Parkinson’s Disease: A Systematic Review and Meta‐Analysis
di: Zahra Hemmatian, et al.
Pubblicazione: (2025)
di: Zahra Hemmatian, et al.
Pubblicazione: (2025)
Genome‐Wide Association Studies Data and Transcriptomics Data Link Herpes Simplex Virus 1 Infection and Parkinson’s Disease
di: Changhao Lu, et al.
Pubblicazione: (2025)
di: Changhao Lu, et al.
Pubblicazione: (2025)
Predictive Value of Brain Volumetry in the Response to Subthalamotomy Using High‐Intensity Focused Ultrasound Treatment in Patients With Parkinson’s Disease
di: Alfaro-Nasta E., et al.
Pubblicazione: (2025)
di: Alfaro-Nasta E., et al.
Pubblicazione: (2025)
Patient‐Reported Outcomes of Rotigotine in Parkinson’s Disease: Real‐World Evidence on Symptom Control and Quality of Life From China
di: Xiaodong Zhu, et al.
Pubblicazione: (2025)
di: Xiaodong Zhu, et al.
Pubblicazione: (2025)
Construction and Identification of Inflammation‐Related TF–mRNA–miRNA Coexpression Network and Immune Infiltration in Parkinson’s Disease
di: Zhuzhen Shen, et al.
Pubblicazione: (2025)
di: Zhuzhen Shen, et al.
Pubblicazione: (2025)
ICF‐Based Assessment of Functioning Problems in Parkinson’s Disease: Findings From a Cross‐Sectional Survey in Southern Ghana
di: Mary Wetani Agoriwo, et al.
Pubblicazione: (2026)
di: Mary Wetani Agoriwo, et al.
Pubblicazione: (2026)
The Use of a Digital Social Forum in a Parkinson’s Disease Risk Cohort: A Thematic Analysis of Forum Messages
di: Laura J. Smith, et al.
Pubblicazione: (2026)
di: Laura J. Smith, et al.
Pubblicazione: (2026)
Method of Tremor Levodopa Responsiveness Assessment and Its Correlation With Clinical Factors in Parkinson’s Disease: Outcomes of the Acute Levodopa Challenge Test
di: Fangfei Li, et al.
Pubblicazione: (2025)
di: Fangfei Li, et al.
Pubblicazione: (2025)
Diagnostic Accuracy of Machine Learning‐Assisted MRI for Mild Cognitive Impairment in Parkinson’s Disease: A Systematic Review and Meta‐Analysis
di: Feng Zhang, et al.
Pubblicazione: (2025)
di: Feng Zhang, et al.
Pubblicazione: (2025)
Cinnamaldehyde Attenuates the Expression of IBA1 and GFAP to Inhibit Glial Cell Activation and Inflammation in the MPTP‐Induced Acute Parkinson’s Disease Model
di: Panpan Jiao, et al.
Pubblicazione: (2024)
di: Panpan Jiao, et al.
Pubblicazione: (2024)
Preoperative Attention/Memory Problem Affects the Quality of Life of Parkinson’s Disease Patients after Deep Brain Stimulation: A Cohort Study
di: Ying Gao, et al.
Pubblicazione: (2024)
di: Ying Gao, et al.
Pubblicazione: (2024)
The Priority Goals and Underlying Impairments Contributing to Goal-Related Problems of People with Parkinson’s Disease Receiving a Community-Based Rehabilitation Program
di: Sarah J. Davies, et al.
Pubblicazione: (2024)
di: Sarah J. Davies, et al.
Pubblicazione: (2024)
EMPOWER‐PD: Evaluation of an 8‐Week Co‐Designed Self‐Management Program in People With Parkinson’s Disease and Their Caregivers: An Intervention Study With Long‐Term Follow‐Up
di: Trine Hørmann Thomsen, et al.
Pubblicazione: (2025)
di: Trine Hørmann Thomsen, et al.
Pubblicazione: (2025)
China’s Modified Version of Sniffin’ Sticks 12‐Identification Test Used in Chinese Parkinson’s Disease and Multiple System Patients: Comparison of Three Olfactory Testing Methods
di: Huijing Liu, et al.
Pubblicazione: (2024)
di: Huijing Liu, et al.
Pubblicazione: (2024)
Alprazolam Reduces Freezing of Gait (FOG) and Improves FOG-Related Gait Deficiencies
di: Abdullah Al Jaja, et al.
Pubblicazione: (2024)
di: Abdullah Al Jaja, et al.
Pubblicazione: (2024)
Focused Ultrasound Thalamotomy for Tremor Relief in Atypical Parkisnsonism
di: Alon Sinai, et al.
Pubblicazione: (2024)
di: Alon Sinai, et al.
Pubblicazione: (2024)
Productivity, Collaboration and Impact of Cuban Scientific Research on Parkinson's Disease in Scopus
di: Piñera-Castro, Hector Julio, et al.
Pubblicazione: (2023)
di: Piñera-Castro, Hector Julio, et al.
Pubblicazione: (2023)
Cepstral Analysis and Hilbert-Huang Transform for Automatic Detection of Parkinson’s Disease
di: Felipe O. López-Pabón
Pubblicazione: (2020)
di: Felipe O. López-Pabón
Pubblicazione: (2020)
Diets, food and Idiopathic Parkinson ́s disease
di: José Perea-Sasiaín
Pubblicazione: (2014)
di: José Perea-Sasiaín
Pubblicazione: (2014)
Baseline α-synuclein seeding activity and Parkinson's disease progression in the Parkinson's Progression Markers Initiative cohort Key Resource Table
di: Schumacher, Jackson
Pubblicazione: (2025)
di: Schumacher, Jackson
Pubblicazione: (2025)
Effect of an Acupuncture Treatment Protocol on the Patellar Reflex in Parkinson's Disease Patients – Case Series Study
di: Pereira, Catarina Ramos, et al.
Pubblicazione: (2025)
di: Pereira, Catarina Ramos, et al.
Pubblicazione: (2025)
Documenti analoghi
-
Association of Specific Leg Muscle Strength and Motor Features in Parkinson’s Disease
di: Chatkaew Pongmala, et al.
Pubblicazione: (2024) -
A Cognitive‐Behavioral Model of Apathy in Parkinson’s Disease
di: Olivia Plant, et al.
Pubblicazione: (2024) -
Trait Impulsivity as a Feature of Parkinson’s Disease Treatment and Progression
di: Holly Spencer, et al.
Pubblicazione: (2024) -
Feasibility and Acceptability of Intervention and Trial Procedures of the UCL Live Well With Parkinson’s Self‐Management Toolkit
di: Tasmin Rookes, et al.
Pubblicazione: (2025) -
Daily Fluid Intake in People With Newly Diagnosed Parkinson’s Disease Is Reduced Compared With Controls
di: Isobel J. Sleeman, et al.
Pubblicazione: (2025)